Increased contribution of small companies to late-entry drugs: a changing trend in FDA-approved drugs during the 2020s
Ryo Okuyama
Topics & Concepts
BusinessDrug discoveryPharmaceutical industryDrugFood and drug administrationNew drug applicationDrug industryApproved drugAlliancePromotion (chess)Drug approvalPharmacologyMarketingMedicineRisk analysis (engineering)BiotechnologyBioinformaticsPoliticsBiologyLawPolitical scienceBiotechnology and Related FieldsScience, Research, and MedicineComputational Drug Discovery Methods